Back to NB Norinchukin Bank, The

REGNREGN

Showing 8 of 28 quarters

Position history for NBNorinchukin Bank, The's holdings in Regeneron Pharmaceuticals, Inc.

Yes. Norinchukin Bank, The holds 10,061 shares of REGN (Regeneron Pharmaceuticals), worth $7.6M, as of its Q3 2026 13F filing. It increased the position by 227 shares (+2.3%) from Q2 2026. Norinchukin Bank, The has listed REGN in each of its last 28 quarterly 13F filings. REGN is 0.1% of Norinchukin Bank, The's reported 13F portfolio.

Current Value

$7.6M

Current Shares

10,061

Total Value Change

+$3.5M

Total Shares Change

+4,251

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
10,061
+2.3%
$7.6M0.1%$758.27
28
2026-Q2
Decreased
9,834
-1.4%
$6.1M0.1%$622.81
0
2026-Q1
Increased
9,979
+3.6%
$7.7M0.1%$770.59
28
2025-Q4
Increased
9,632
+9.3%
$7.4M0.1%$768.90
30
2025-Q3
Decreased
8,811
-3.8%
$5M0.1%$559.40
0
2025-Q2
Increased
9,154
+9.3%
$4.8M0.1%$521.53
29
2025-Q1
Increased
8,378
+44.2%
$5.3M0.1%$629.11
36
2024-Q4
Increased
5,810
+8.9%
$4.1M0.1%$705.67
29

Optional analytics helps us improve. How it’s used